In a significant development in the fight against COVID-19, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting the virus. This landmark decision, announced last ...

The World Health Organization (WHO) has reached a pivotal moment in the fight against COVID-19 by prequalifying the first two rapid antigen diagnostic tests for SARS-CoV-2. This groundbreaking ...

WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic ...

The SD Biosensor Standard Q COVID-19 Ag Test and Acon Biotech Flowflex SARS-CoV-2 Antigen Rapid Test were previously listed under WHO's emergency use listing.

Since the start of the pandemic, the FDA has issued emergency use authorizations to a whopping 444 diagnostic tests and sample collection devices to detect the COVID-19 virus. In recent months, ...

Rapid antigen tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are effective tools for the diagnosis of acute infection, particularly when used serially. 1 The percentage of ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...

RSV is short for respiratory syncytial virus. It’s a virus that can cause respiratory infections in your lungs, nose, and throat. It’s best to test for RSV soon after your symptoms start. That’s ...